BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29091007)

  • 21. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.
    Houssami N; Abraham LA; Kerlikowske K; Buist DS; Irwig L; Lee J; Miglioretti DL
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):946-61. PubMed ID: 23513042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic density and estimation of breast cancer risk in intermediate risk population.
    Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
    Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of mammographic density and age: implications for breast cancer screening.
    Checka CM; Chun JE; Schnabel FR; Lee J; Toth H
    AJR Am J Roentgenol; 2012 Mar; 198(3):W292-5. PubMed ID: 22358028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer detected with screening US: reasons for nondetection at mammography.
    Bae MS; Moon WK; Chang JM; Koo HR; Kim WH; Cho N; Yi A; Yun BL; Lee SH; Kim MY; Ryu EB; Seo M
    Radiology; 2014 Feb; 270(2):369-77. PubMed ID: 24471386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influences of Radiology Trainees on Screening Mammography Interpretation.
    Hawley JR; Taylor CR; Cubbison AM; Erdal BS; Yildiz VO; Carkaci S
    J Am Coll Radiol; 2016 May; 13(5):554-61. PubMed ID: 26924162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.
    Kim EY; Chang Y; Ahn J; Yun JS; Park YL; Park CH; Shin H; Ryu S
    Cancer; 2020 Nov; 126(21):4687-4696. PubMed ID: 32767699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts.
    Rechtman LR; Lenihan MJ; Lieberman JH; Teal CB; Torrente J; Rapelyea JA; Brem RF
    AJR Am J Roentgenol; 2014 Feb; 202(2):293-8. PubMed ID: 24450668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
    Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
    Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.
    Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK
    Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy.
    Freitas V; Scaranelo A; Menezes R; Kulkarni S; Hodgson D; Crystal P
    Cancer; 2013 Feb; 119(3):495-503. PubMed ID: 22952042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using sonography to screen women with mammographically dense breasts.
    Crystal P; Strano SD; Shcharynski S; Koretz MJ
    AJR Am J Roentgenol; 2003 Jul; 181(1):177-82. PubMed ID: 12818853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.
    Rhodes DJ; Hruska CB; Conners AL; Tortorelli CL; Maxwell RW; Jones KN; Toledano AY; O'Connor MK
    AJR Am J Roentgenol; 2015 Feb; 204(2):241-51. PubMed ID: 25615744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does digital mammography increase detection of high-risk breast lesions presenting as calcifications?
    Neal CH; Coletti MC; Joe A; Jeffries DO; Helvie MA
    AJR Am J Roentgenol; 2013 Nov; 201(5):1148-54. PubMed ID: 24147490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.